The impact of the sanctions made against Iran on availability to asthma medicines in Tehran

Iranian Journal of Pharmaceutical Research

Volumn 15, Issue 3, 2016, Pages 567-571

  Ghiasi, Golbarg ^a   Rashidian, Arash ^b   Kebriaeezadeh, Abbas ^a,c   Salamzadeh, Jamshid ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Asthma medicines; Availability; Pharmacies; Sanction

Indexed keywords

ANTIASTHMATIC AGENT; BECLOMETASONE; BECLOMETASONE DIPROPIONATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYTOKINE; FLUTICASONE; FLUTICASONE PROPIONATE PLUS SALMETEROL XINAFOATE; LEUKOTERIAN; MUSCARINIC RECEPTOR BLOCKING AGENT; SALBUTAMOL; UNCLASSIFIED DRUG;

ARTICLE; ASTHMA; ECONOMIC ASPECT; ECONOMIC SANCTION; HEALTH CARE ACCESS; HUMAN; INTERVIEW; IRAN; MEDICINE; PHARMACIST; PHARMACY; QUESTIONNAIRE;

EID: 84990038448     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Zaidi SH, Bigdeli M, Aleem N and Rashidian A. Access to essential medicines in Pakistan: Policy and health systems research concerns. PLOS. ONE. (2013) 8:1-10.
2. Gholamhossein M, Nazila Y, Hashemian F and Maleksabet H. Knowledge, attitude and practice of pharmacists regarding dietary supplements: A community pharmacy- based survey in Tehran. Iran. J. Pharm. Res. (2014) 13: 1457-65.
3. Mehralian G and Bastani P. Pharmaceutical strategic purchasing: a key to improve access to medicines. Iran. J. Pharm. Res. (2015) 14: 345-6
4. Rashidian A, Jahanmehr N and Jabbour S. Bibliographic review of research publications on access to and use of medicines in low-income and middle-income countries in the Eastern Mediterranean Region: identifying the research gaps. BMJ. Open. (2013) 3: 32-3.
5. Cheraghali AM, Nikfar S, Behmanesh Y, Rahimi V, Habibipour F, Tirdad R, Asadi A and Bahrami A. Evaluation of availability, accessibility and prescribing pattern of medicines in the Islamic Republic of Iran. East. Mediterr. Health (2004) 10: 406-415.
6. Mbanje B and Mahuku DN. European Union sanctions and their impacts on Zimbabwe 2002 –2011: finding alternative means to survive. Sacha. Policy Strategic Study (2011) 1: 1-12.
7. Hosseini SA. Impact of sanctions on procurement of medicine and medical devices in Iran; A technical response. Arch. Iran. Med. (2013) 16: 736-8.
8. Robinson CB, Leonard J and Panettieri RA Jr.. Drug development for severe asthma: What are the metrics? Pharmacol. Ther. (2012) 135: 176-181.
9. Masoli M, Fabian D, Holt S and Beasley R. Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy (2004) 59: 469-478.
10. Mullane K. The increasing challenge of discovering asthma drugs. Biochem. Pharmacol. (2011) 82: 586-599.
11. Gibbons E and Garfield R. The impact of economic sanctions on health and human rights in Haiti, 1991– 1994. Am. Public Health (1999) 89: 1499-1504.
12. Mendis S, Fukino K, Cameron A, Laing R and Filipe A. The availability and affordability of selected essential medicines for chronic diseases in six low-and middle-income countries. Bull. World Health Organ. (2007) 85: 279-88.
13. Kebriaeezadeh A, Koopaei NN, Abdollahiasl A, Nikfar S and Mohamadi N. Trend analysis of the pharmaceutical market in Iran; 1997-2010; policy implications for developing countries. DARU: J. Pharm. Sci. (2013) 21: 52
14. Mohammadzadeh M. Alignment is the most efficient tool in the management of the pharmaceutical turbulent market. Iran. J. Pharm. Res. (2014) 13: 1-2
15. Oraka E and Shen J. Complementary and alternative medicine (CAM) use among children with current asthma. Prev. Med. (2012) 54: 27-31.
16. Adams RJ, Smith BJ and Ruffin RE. Factors associated with hospital admissions and repeat emergency department visits for adults with asthma. Thorax. (2000) 55: 566-73.
17. Rajaee Fard A, Mousa Zadeh A, Pour Mohammdi A, Naeemi E, HadiNia A and Karimi A. Prevalence of asthma and related factors in children under six with logistic regression and probity models. Armaghan Danesh (2011) 16: 272-281.
18. Cameron A, Roubos I, Ewen M, Aukje K, Hubertus GM and Richard O. Differences in the availability of medicines for chronic and acute conditions in the public and private sector of developing countries. Bull. World Health Organ. (2011) 89: 412-21.